Analysis of pharmacogenomic factors for chemotherapy-induced nausea and vomiting in patients with breast cancer receiving doxorubicin and cyclophosphamide chemotherapy
Daiki Tsuji, Megumi Matsumoto, Yohei Kawasaki, Yong-I. L. Kim, Keisuke Yamamoto, Hidenori Nakamichi, Yuri Sahara, Ryo Makuta, Mari Yokoi, Takehiro Miyagi, Kunihiko Itoh
Topics & Concepts
AprepitantCyclophosphamideMedicineChemotherapyInternal medicineNauseaVomitingAntiemeticBreast cancerGastroenterologyChemotherapy-induced nausea and vomitingOncologyDoxorubicinCancerNausea and vomiting managementAnesthesia and Pain ManagementAnesthesia and Sedative Agents